SEC Form 4 research
| Issuer | Amneal Pharmaceuticals, Inc. |
|---|---|
| Tickers | AMRX |
| Reporting owners | 40 |
| Officers and directors | 16 |
| Last public filing | 2026-08-15 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-13 | Kiely John | S | 50,000 | $17.64 | Not reported |
| 2026-08-13 | 2026-08-12 | Shah Nikita | S | 146,403 | $17.51 | Not reported |
| 2026-08-13 | 2026-08-12 | Daly Jason B. | S | 210,000 | $17.4 | Not reported |
| 2026-08-13 | 2026-08-11 | Daly Jason B. | S | 6,613 | $17.7 | Not reported |
| 2026-08-12 | 2026-08-10 | Patel Chintu | A | 6,381,734 | Not reported | Not reported |
| 2026-08-12 | 2026-08-10 | Patel Gautam | A | 283,632 | Not reported | Not reported |
| 2026-08-12 | 2026-08-10 | Patel Chirag K. | A | 6,381,734 | Not reported | Not reported |
| 2026-08-12 | 2026-08-10 | Patel Tushar Bhikhubhai | A | 12,763,469 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.